“Alteration of Panel-Reactive Antibodies Following Treatment With Either Atorvastatin or Low-Dose Mycophenolate Mofetil in Sensitized Hemodialysis Patients”. Iranian Journal of Kidney Diseases, vol. 5, no. 5, Aug. 2011, pp. 342-6, https://ijkd.org/index.php/ijkd/article/view/364.